Christopher J Lisanti - Schertz, Texas 78154

Christopher J Lisanti is categorized under Doctors in Schertz, TX .

Business Name: Christopher J Lisanti
Contact Person: Christopher J Lisanti
Address: 494 Cedar Bridge, Schertz, Texas 78154
Phone Number: (210) 658-9713
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:
Related Businesses: Dr Hilda B Gonzalez-Saenz Md - Schertz, TX 78154
Swift Bernard T DO - Schertz, TX 78154
Northeast Pediatric Assoc - Schertz, TX 78154
Dr Phonez - Schertz, TX 78154
Northeast Pediatric Assoc - Schertz, TX 78154
Araujo Julio C MD - Schertz, TX 78154
Molinar Jose M MD - Schertz, TX 78154
Jaffer Salima MD - Schertz, TX 78154
Brown Ambur L MD - Schertz, TX 78154
Holmes Peter MD - Schertz, TX 78154
Akright Laura S MD - Schertz, TX 78154
Murray Jr James P MD - Schertz, TX 78154
John E Lee Sang M D P A - Schertz, TX 78154
Wright Gloria DO - Schertz, TX 78154
Wright Jr Anthony R DO - Schertz, TX 78154
Clinton L Holt Dr - Schertz, TX 78154
Ottmers Jeffrey N MD - Schertz, TX 78154
Lopez Joseph MD - Schertz, TX 78154
Jeremiah Brown MD - Schertz, TX 78154
Well Med - Schertz, TX 78154

The company Christopher J Lisanti provides B2C services in the form of Doctors from its single location in Texas. 1 to 4 employees work for Christopher J Lisanti, and the business now earns $100.000 to $499.999 per annum.

Christopher J Lisanti was launched in 2008 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 . To contact Christopher J Lisanti, please call Christopher J Lisanti with the phone number (210) 658-9713 or visit its single location at 494 Cedar Bridge in Schertz, Texas 78154.

The location of the single location can also be found using the coordinates 29.575584,-98.277706. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.